Celularity, Inc. (CELU)
1.40
-0.07
(-4.76%)
USD |
NASDAQ |
Oct 13, 16:00
1.44
+0.04
(+2.86%)
After-Hours: 20:00
Celularity Free Cash Flow : -8.814M for March 31, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2026 | -8.814M |
| December 31, 2025 | -13.25M |
| September 30, 2025 | -8.113M |
| June 30, 2025 | -4.133M |
| March 31, 2025 | -6.613M |
| December 31, 2024 | -8.062M |
| September 30, 2024 | -13.02M |
| June 30, 2024 | -21.39M |
| March 31, 2024 | -28.97M |
| December 31, 2023 | -42.73M |
| September 30, 2023 | -68.18M |
| June 30, 2023 | -98.91M |
| March 31, 2023 | -125.61M |
| Date | Value |
|---|---|
| December 31, 2022 | -143.11M |
| September 30, 2022 | -147.10M |
| June 30, 2022 | -143.70M |
| March 31, 2022 | -125.45M |
| December 31, 2021 | -116.30M |
| September 30, 2021 | -108.15M |
| June 30, 2021 | -136.32M |
| March 31, 2021 | -117.04M |
| December 31, 2020 | -91.03M |
| September 30, 2020 | -65.05M |
| June 30, 2020 | -1.677M |
| March 31, 2020 | -1.647M |
| December 31, 2019 | -1.098M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Tenax Therapeutics, Inc. | -46.03M |
| Exicure, Inc. | -6.385M |
| Century Therapeutics, Inc. | -88.07M |
| Absci Corp. | -108.97M |
| Cardio Diagnostics Holdings, Inc. | -6.106M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.447M |
| Cash from Financing (Quarterly) | -7.342M |
| Free Cash Flow Per Share (Quarterly) | 0.0478 |
| Free Cash Flow to Equity (Quarterly) | 8.08M |
| Free Cash Flow to Firm (Quarterly) | 1.799M |
| Free Cash Flow Yield | -23.00% |